Related Experiment Video
Updated: Jun 25, 2026
A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules
Published on: May 19, 2023
Benchmarking of AI and Radiologists for Indeterminate Lung Nodule Malignancy Risk Estimation at Screening CT: The
Dré Peeters1, Bogdan Obreja1, Noa Antonissen1
1Diagnostic Image Analysis Group, Department of Medical Imaging, Radboudumc, Radboud University Medical Center, Route 767, Room 2.30, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, the Netherlands.
Abstract:
Purpose To compare the performance of an artificial intelligence (AI) system with that of radiologists for estimating malignancy risk of indeterminate-size nodules (5-15 mm) at low-dose CT (LDCT) within a standardized and transparent evaluation framework. Materials and Methods Teams participating in the AI study had access to a public dataset of 555 malignant and 5608 benign nodules on 4069 baseline LDCT scans from the National Lung Screening Trial to develop AI systems. External testing was performed on 156 malignant and 312 benign size-matched nodules, all of indeterminate size, from 463 baseline scans collected from three large European lung cancer screening trials, and the best-performing AI system (based on area under the receiver operating characteristic curve [AUC]) was selected. An observer study was conducted in which radiologists assessed 300 randomly selected nodules (100 malignant, 200 benign) from the external test set. Radiologists categorized nodules as low, intermediate, or high risk, and the threshold of intermediate or greater risk (intermediate or high-risk) was used to define a positive test result. The selected AI system was compared with radiologists on this subset using the AUC. Results The selected AI system demonstrated superior performance to the 65 radiologists' mean (AUC, 0.78 [95% CI: 0.73, 0.84] vs 0.70 [95% CI: 0.65, 0.74]; P = .001). With use of the intermediate risk or greater threshold, the AI system correctly classified 12% more malignant nodules at matched specificity and yielded 20% fewer false-positive results at matched sensitivity. Conclusion The selected AI system was superior to radiologists in estimating malignancy risk of indeterminate lung nodules at LDCT. Keywords: CT, Thorax, Lung, Observer Performance, Screening, Supervised Learning, Lung Cancer Screening, Radiologists, Artificial Intelligence, Benchmarking, Pulmonary Nodule Malignancy Risk, Deep Learning Supplemental material is available for this article. © RSNA, 2026 See also commentary by Júdice de Mattos Farina and Szarf in this issue.
